Massive re rate coming for GTG in 2021, page-10

I read the presentation released last night and have sent the following to the Company for clarification. I'd appreciate any comments or thoughts on it please.

____________________________________________________________

I'm just reading the investor presentation for the 2021 Bio Connect conference and would appreciate some clarification regarding the Covid19 test.

During video presentation last year, Dr. George Muchnicki was hopeful that the Covid19 test would be released to the market prior to Christmas 2020. If not he predicted the test to be released early in 2021.

Then it was released that the Company had received a fresh data set and that the release would be delayed by four weeks.

Now when I read the presentation it states that the Covid19 test is 'expected' to be ready for market release in Q1 CY21.

That means that it could be at the end of March 2021.

Then when I read slide 11 it states that the release is within the first half of CY21.

Considering George was hopeful for the test to be released prior to 25th December 2020 and now it may be stretched out to the end of June 2021 this is potentially quite a long delay.

Can you please clarify from what date the 'four week delay' commences? Does the delay start from Christmas day last year, the start of 2021 or is it a four week delay from the end of Q1 2021?